Skip to content

Levels of Circulating T Cells Expressing VLA-1 Collagen Receptors

VLA-1 Receptors on Peripheral T Cells in Ischemic Heart Disease Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00708838
Enrollment
151
Registered
2008-07-02
Start date
2002-01-31
Completion date
2007-02-28
Last updated
2008-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Heart Disease

Brief summary

The examination of the percentage of peripheral T cells carrying VLA-1 in ischemic heart disease patients. The hypothesis is that the percentage levels of cells carrying this integrin rise according to the severity of the ischemic heart disease.

Detailed description

Atherosclerosis is considered an inflammatory disease in which lymphocytes have an important role. The study was disigned to find out the changes in T cell levels carrying VLA-1 involvement in this process.

Interventions

None listed

Sponsors

Sheba Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* clinical diagnosis of acute MI for group 1 * clinical diagnosis of ACSl for group 2 * clinical diagnosis of Chronic Heart Disease for groups 3 and 4 * Chest pain but normal heart scan for group 5

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frame
The differance in percentage of T cells in the 5 different groups involved.2002-2006

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026